Table: Kringle Pharma - 6-MTH parent results

Kringle Pharma

13/05/2024 07:40

May 13 (Reuters)- 
             Kringle Pharma, Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended        Year to   
                Mar 31, 2024        Mar 31, 2023       Sep 30, 2024  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Sales            43 mln              34 mln            272 mln     
                 (+25.3 pct)         (+25.8 pct)       (+292.8 pct)  
  Operating     loss 366 mln        loss 314 mln        loss 1.13    
  Recurring     loss 365 mln        loss 314 mln        loss 1.11    
  Net           loss 366 mln        loss 315 mln        loss 1.11    
  EPS          loss 60.21 yen      loss 58.63 yen    loss 176.14 yen 
  Ann Div                                NIL               NIL       
  -Q2 div            NIL                                             
  -Q4 div                                NIL               NIL       
  
  NOTE - Kringle Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4884.T